Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Hoffmann

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
BMC Neurology|December 25, 2015
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot studySarah Hoffmann, Jana Siedler, Alexander U Brandt, et al.
Journal of Neurology|August 12, 2022
Correction to: Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
Neuromuscular Disorders : NMD|February 6, 2023
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravisSarah Hoffmann, Patrick Waters, Leslie Jacobson, et al.
Stroke|July 17, 2012
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic strokeSarah Hoffmann, Uwe Malzahn, Hendrik Harms, et al.
Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.
Cell Reports|January 5, 2017
Interplay between Obesity-Induced Inflammation and cGMP Signaling in White Adipose TissueAbhishek Sanyal, Jennifer Naumann, Linda Sarah Hoffmann, et al.
Neuromuscular Disorders : NMD|February 6, 2026
Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case reportStefan Verlohren, Christof Dame, Beate Mayer, et al.
Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.
Journal of Neurology|November 20, 2021
Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
Brain Pathology (Zurich, Switzerland)|January 17, 2014
Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)Sarah Hoffmann, Jill Murrell, Lutz Harms, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
BMC Neurology|December 25, 2015
Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot studySarah Hoffmann, Jana Siedler, Alexander U Brandt, et al.
Journal of Neurology|August 12, 2022
Correction to: Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
Neuromuscular Disorders : NMD|February 6, 2023
Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravisSarah Hoffmann, Patrick Waters, Leslie Jacobson, et al.
Stroke|July 17, 2012
Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic strokeSarah Hoffmann, Uwe Malzahn, Hendrik Harms, et al.
Frontiers in Immunology|April 23, 2025
The burden of disease in seronegative myasthenia gravis: a patient-centered perspectiveSophie Lehnerer, Regina Stegherr, Ulrike Grittner, et al.
Cell Reports|January 5, 2017
Interplay between Obesity-Induced Inflammation and cGMP Signaling in White Adipose TissueAbhishek Sanyal, Jennifer Naumann, Linda Sarah Hoffmann, et al.
Neuromuscular Disorders : NMD|February 6, 2026
Preemptive immunotherapy for fetal acetylcholine receptor antibody disorder (FARAD): from recurrent pregnancy losses to a healthy infant - a case reportStefan Verlohren, Christof Dame, Beate Mayer, et al.
Journal of Autoimmunity|April 18, 2026
Impact of a ketogenic diet on clinical outcomes and immunological markers in myasthenia gravis: A randomized pilot studyBenjamin Makus, Daniel Schulze, Sophie Lehnerer, et al.
Journal of Neurology|November 20, 2021
Burden of disease in myasthenia gravis: taking the patient's perspectiveSophie Lehnerer, Jonas Jacobi, Ralph Schilling, et al.
Brain Pathology (Zurich, Switzerland)|January 17, 2014
Enlarging the nosological spectrum of hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS)Sarah Hoffmann, Jill Murrell, Lutz Harms, et al.
Pageof 9